Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- The Texas Medical Center Library (14)
- Dartmouth College (5)
- Aga Khan University (1)
- Claremont Colleges (1)
- Clemson University (1)
-
- East Tennessee State University (1)
- Eastern Washington University (1)
- Missouri State University (1)
- Rollins College (1)
- The University of San Francisco (1)
- Touro College and University System (1)
- University of Louisville (1)
- University of Nebraska Medical Center (1)
- Virginia Commonwealth University (1)
- West Virginia University (1)
- Western Kentucky University (1)
- Wilfrid Laurier University (1)
- Keyword
-
- Immunotherapy (6)
- Immunology (4)
- Melanoma (4)
- Cancer (3)
- Dendritic cells (3)
-
- Biomarker (2)
- MHC class I (2)
- PD-L1 (2)
- Radiotherapy (2)
- Tumor microenvironment (2)
- Vaccination (2)
- Vaccines (2)
- 4T1 (1)
- 96-well plate (1)
- AP-1 component dosage in memory CD8 T cell subsets (1)
- Abscopal effect (1)
- Alfred Russel Wallace (1)
- Allo-rejection (1)
- Alloreactive Natural Killer Cell (1)
- Anivaccination (1)
- Antibody (1)
- Antigen cross-presentation (1)
- Antigen presentation (1)
- Assay (1)
- Asthma (1)
- B. pertussis (1)
- B16F10 (1)
- Bioethics (1)
- Bioinformatic tools (1)
- Bioinformatics (1)
- Publication
-
- Dissertations and Theses (Open Access) (14)
- Dartmouth College Ph.D Dissertations (5)
- 2026 Symposium (1)
- All Theses (1)
- Centre for Regenerative Medicine & Stem Cell Research (1)
-
- Electronic Theses and Dissertations (1)
- Faculty/Staff Personal Papers (1)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (1)
- Graduate Theses/Dissertations (1)
- Honors Program Theses (1)
- KGI Theses and Dissertations (1)
- Master's Theses (1)
- NYMC Student Theses and Dissertations (1)
- The University of Louisville Journal of Respiratory Infections (1)
- Theses & Dissertations (1)
- Theses and Dissertations (1)
- Theses and Dissertations (Comprehensive) (1)
- Publication Type
Articles 31 - 34 of 34
Full-Text Articles in Immunotherapy
Exosomal Communication By Metastatic Osteosarcoma Cells Modulates Alveolar Macrophages To An M2 Tumor-Promoting Phenotype And Inhibits Tumoricidal Functions, Kerri Wolf
Dissertations and Theses (Open Access)
Osteosarcoma metastasizes to the lung, and there is a link between the predominance of tumor promoting immunosuppressive M2 macrophages in the metastases and poor patient survival. By contrast, M1macrophage predominance correlates with longer survival. M2 macrophages can be induced by various stimuli in the tumor microenvironment, including exosomes, which are 40- to 150-nm vesicles that are involved in intercellular communication and contribute to tumor progression and immune evasion. Recognizing that tumor cells can influence the tumor microenvironment to make it more permissive and because of the link between M2 dominance and curtailed patient survival, we evaluated the effect of …
Loss Of Caspase-8 Function In Combination With Smac Mimetic Treatment Sensitizes Head And Neck Squamous Carcinoma To Radiation Through Induction Of Necroptosis., Burak Uzunparmak
Loss Of Caspase-8 Function In Combination With Smac Mimetic Treatment Sensitizes Head And Neck Squamous Carcinoma To Radiation Through Induction Of Necroptosis., Burak Uzunparmak
Dissertations and Theses (Open Access)
Caspase-8 (CASP8) is one of the most frequently mutated genes in Head and Neck Squamous Carcinomas (HNSCC), and mutations of CASP8 are associated with poor overall survival. The distribution of these mutations in HNSCC suggests that they are likely to be inactivating. Inhibition of CASP8 has been reported to sensitize cancer cells to necroptosis, a unique cell death mechanism. Here, we evaluated how CASP8 regulates necroptosis in HSNCC using cell line models and syngeneic mouse xenografts. In vitro, knockdown of CASP8 rendered HNSCCs susceptible to necroptosis induced by a second mitochondria-derived activator of caspase (SMAC) mimetic, Birinapant, when combined …
Immunotherapy: Therapy Vs. Enhancement, Mariah Daly
Immunotherapy: Therapy Vs. Enhancement, Mariah Daly
Honors Program Theses
The battle against cancer is a long-standing struggle that has resulted in new information and the development of novel medical technologies. Current research aims to figure out a way to reprogram cells and bodily mechanisms to eliminate those cells that are cancerous without destroying healthy cells in the process. Methods which use the body’s own mechanisms, such as immunotherapy, have shown and continue to show potential for specifically targeting cancer cells. Adoptive T cell therapy is one form of immunotherapy that has gained significant attention and focus in the field. Therapies improve conditions up to the normal state of being, …
Augmenting Guadecitabine To Promote Anticancer Immunity In Murine Breast Cancer, Timothy M. Smith Jr.
Augmenting Guadecitabine To Promote Anticancer Immunity In Murine Breast Cancer, Timothy M. Smith Jr.
Theses and Dissertations
In immune-competent individuals, tumor growth occurs due to a failure of the immune system to recognize and destroy malignant cells. Immune surveillance can be curtailed by the presence of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and T-regulatory cells (Tregs) which both serve to dampen antitumor immunity. These studies utilize a metronomic low-dose therapeutic approach to examine the effects of anticancer drugs against murine breast cancer and the effects on the immune cell compartments. The focus of these studies revolve around the drug guadecitabine (guad), a second-generation DNA methyl-transferase inhibitor (DNMTi). DNMTi’s have been shown to dysregulate the methylation …